Background Despite COVID-19 being identified as severe respiratory viral infection,
progressively many relevant endocrine manifestations have been reported greatly …

Abstract Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality
rates globally, representing the greatest health and economic challenge today. Several …

Objectives Superinfections in patients hospitalized in intensive care unit (ICU) are an
important and challenging complication, also in COVID-19. However, no definitive data are …

The coronavirus disease 2019 (COVID-19) pandemic caused significant disruption to
teaching and learning activities at all levels. Faculty, students, institutions, and parents have …

Background We retrospectively data-mined the case records of Reverse Transcription
Polymerase Chain Reaction (RT-PCR) confirmed COVID-19 patients hospitalized to a …

Background and objectives Corticosteroids are commonly used in the treatment of
hospitalized patients with COVID-19. The goals of the present study were to compare the …

Besides the pulmonary manifestations caused by severe acute respiratory syndrome
(SARS) coronavirus 2 (SARS-CoV-2), an emerging endocrine phenotype, which can heavily …

The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

Objective The preferred agent of glucocorticoids in the treatment of patients with severe
COVID-19 is still controversial. This study aimed to compare the efficacy and safety of …

Objectives To update the EULAR points to consider (PtCs) on the use of immunomodulatory
therapies in COVID-19. Methods According to the EULAR standardised operating …